116 related articles for article (PubMed ID: 4353558)
21. [Study of distrubance of water metabolism in a case of panhypopituitarism].
Godard C; de Sousa RC; Pilloud P
Ann Paediatr; 1965; 205(5):355-80. PubMed ID: 5898605
[No Abstract] [Full Text] [Related]
22. [On the antidiuretic action of angiotensin II and of furosemide in a case of renal diabetes insipidus].
Salvetti A; Arzilli P; Russo R
Minerva Pediatr; 1973 Aug; 25(27):1198-201. PubMed ID: 4356508
[No Abstract] [Full Text] [Related]
23. [Diabetes insipidus (classification, diagnosis, therapy)].
Uhlich E; Buchborn E
Internist (Berl); 1972 Apr; 13(4):141-7. PubMed ID: 4555566
[No Abstract] [Full Text] [Related]
24. A vasopressin analogue in treatment of diabetes insipidus.
Kauli R; Laron Z
Arch Dis Child; 1974 Jun; 49(6):482-5. PubMed ID: 4850356
[TBL] [Abstract][Full Text] [Related]
25. [On the problems of synthetic polypeptides on the basis of oxytocin].
Holecek V
Vnitr Lek; 1969 May; 15(5):435-41. PubMed ID: 5792536
[No Abstract] [Full Text] [Related]
26. Effects of prolonged administration of vasopressin on plasma sodium and on renal excretion of electrolytes and water.
Chan WY
J Pharmacol Exp Ther; 1971 Jul; 178(1):141-51. PubMed ID: 5087392
[No Abstract] [Full Text] [Related]
27. Studies with angiotensin in nephrogenic diabetes insipidus.
Orr FR; Filipich RL
Can Med Assoc J; 1967 Sep; 97(14):841-5. PubMed ID: 4293073
[No Abstract] [Full Text] [Related]
28. Clinical value of the combinations of carbamazepine (tegretol), chlorpropamide (diabinese) and vasopressin in the treatment of pituitary diabetes insipidus.
Radó JP; Marosi J; Szende L; Takó J
Endokrinologie; 1973 Dec; 62(3):297-309. PubMed ID: 4790811
[No Abstract] [Full Text] [Related]
29. A case of hypopituitarism with diabetes insipidus and loss of thirst. Role of antidiuretic hormone and angiotensin II in the control of urine flow and osmolality.
Trust PM; Brown JJ; Chinn RH; Lever AF; Morton JJ; Padfield PL; Robertson JI; Ireland JT; Melville ID; Thomson WS
J Clin Endocrinol Metab; 1975 Aug; 41(2):346-53. PubMed ID: 1171897
[TBL] [Abstract][Full Text] [Related]
30. [Clinical trial of a vasopressin analog, DDAVP, in 4 patients with diabetes insipidus].
Borner W; Froesch ER
Schweiz Med Wochenschr; 1974 Apr; 104(16):579-82. PubMed ID: 4827026
[No Abstract] [Full Text] [Related]
31. Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin) in the treatment of diabetes insipidus in children.
Némethová V; Lichardus B
Endokrinologie; 1974 Mar; 63(1):137-41. PubMed ID: 4611759
[No Abstract] [Full Text] [Related]
32. Effects of yohimbine and prazosin on water balance in dogs with diabetes insipidus.
Montastruc JL; Dang Tran L; Castillo-Ferrando JR; Morales-Olivas F; Gaillard-Plaza G; Montastruc P
J Pharmacol; 1980; 11(4):441-8. PubMed ID: 7206732
[No Abstract] [Full Text] [Related]
33. The management of postoperative diabetes insipidus.
Wise BL
J Neurosurg; 1966 Oct; 25(4):416-20. PubMed ID: 5925712
[No Abstract] [Full Text] [Related]
34. Lypressin (Diapid) and other drugs for diabetes insipidus.
Med Lett Drugs Ther; 1972 Dec; 14(26):98-9. PubMed ID: 4648574
[No Abstract] [Full Text] [Related]
35. Factitious hyposthenuria.
Sapira JD
Am J Med; 1972 Dec; 53(6):801-4. PubMed ID: 4634734
[No Abstract] [Full Text] [Related]
36. Diabetes insipidus and other disorders of water balance.
Oberfield SE
Pediatr Ann; 1980 Oct; 9(10):384-9. PubMed ID: 7003519
[No Abstract] [Full Text] [Related]
37. [Angiotensin II: its possible role in homeostasis of extracellar fluid volume].
Agnoli GC; Cariani A; Garutti C; Montini T
G Clin Med; 1974 Mar; 55(3):161-236. PubMed ID: 4372117
[No Abstract] [Full Text] [Related]
38. Centrally mediated hydration effects of angiotensin in various states of sodium balance.
Kapsha JM; Keil LC; Klase PA; Severs WB
Pharmacology; 1979; 18(1):25-33. PubMed ID: 419158
[No Abstract] [Full Text] [Related]
39. ADH-associated pathologies. Diabetes insipidus and syndrome of inappropriate ADH.
Abrams C
MLO Med Lab Obs; 2000 Feb; 32(2):24-8, 30, 32-3; quiz 36, 38. PubMed ID: 10787887
[No Abstract] [Full Text] [Related]
40. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide).
Radó JP; Marosi J; Takó J
Endokrinologie; 1970; 55(5):359-65. PubMed ID: 5439569
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
